More compact doses for perioral treatment than for upper facial applications are applied since the oral musculature responds far more strongly to the same BTX-A dosing. Just one preparation of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indicator and FDA approval lies in treatments of cervical dystonia.Porta M. A comparative dem